Biomarkers of pulmonary arterial hypertension of congenital heart disease and their significance / 心血管康复医学杂志

ABSTRACT

Pulmonary arterial hypertension(PAH)is a frequent complication of congenital heart disease(CHD), which seriously affects survival rate and quality of life in these patients.Therefore,some standard,noninvasive and objective biomarkers are needed in clinic,which are meaningful for early diagnosis,severity assessment,therapeutic method selection,therapeutic effect evaluation and prognosis judgment of PAH.The present article made a review about research on biomarkers related to PAH.